Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-99.68	53.06	16398.29
Graham Fair Price	76.03	1.07	0.61
PEG	-92.89	-0.06	0.83
Price/Book	-27.72	1.93	2.68
Price/Cash Flow	-1.90	-27.63	-27.12
Prices/Earnings	-76.64	24.52	-104.98
Price/Sales	-45.26	8.13	14.86
Price/FCF	-1.90	-27.63	-27.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	55.80	0.28	0.18
Operating Margin	369.09	0.11	-0.02
ROA	215.13	< 0.005	< 0.005
ROE	< 0.005	0.02	209.48
ROIC	< 0.005	0.02	357.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.24	< 0.005	-3146.05
Dividends QOQ	-0.65	9.85	1405.26
EBIT QOQ	-1.16	7.20	521.11
EPS QOQ	-1.26	4.14	228.64
FCF QOQ	-1.56	0.29	-81.38
Revenue QOQ	-0.45	0.32	-28.58
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	8.53	10.83	26.95
Days Sales Outstanding (DSO)	116.05	99.73	-14.06
Inventory Turnover	10.55	8.31	-21.23
Debt/Capitalization	0.25	0.23	-6.10
Quick Ratio	0.78	0.95	22.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.61	1.87	16.07
Cash	0.70	0.60	-15.11
Capex	-0.05	< 0.005	-87.75
Free Cash Flow	-0.16	-0.11	29.02
Revenue	0.29	0.38	32.12
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.93	0.98	4.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	165.13	-0.49	-99.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating